Zevra Therapeutics(ZVRA)
$9.08-2.08 (-18.64%)
ZVRA
Zevra Therapeutics ownership
$9.08
At close:-2.08 (-18.64%)
Want to see ZVRA full AI Analyst Report?
Zevra Therapeutics (ZVRA) Ownership - Who Owns Zevra Therapeutics?
1,159 Followers
Zevra Therapeutics (ZVRA) Ownership Overview
- 1.46% Insiders
- 17.08% Mutual Funds
- 21.88% Other Institutional Investors
- 16.89% ETFs
- 42.70% Public Companies and Individual Investors
The ownership structure of Zevra Therapeutics (ZVRA) stock is a mix of institutional, retail, and individual investors. Approximately 55.84% of the company’s stock is owned by Institutional Investors, 1.46% is owned by Insiders, and 42.70% is owned by Public Companies and Individual Investors.
The ownership structure of Zevra Therapeutics (ZVRA) stock is a mix of institutional, retail, and individual investors. Approximately 55.84% of the company’s stock is owned by Institutional Investors, 1.46% is owned by Insiders, and 42.70% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 11, 2026 | Corey Michael Watton | $138,375 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2026 | $56,339,178 | ||
| Sep 30, 2026 | Entrypoint Capital, Llc | $147,481 | |
| Sep 30, 2026 | Royce & Associates Llc | $9,973,233 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 5,135,750 | Institution | 8.63% | 46,632,610 |
| Michael Rockefeller | 4,785,771 | Institution | 8.04% | 43,454,801 |
| Fidelity Contrafund | 3,573,106 | Institution | 6.00% | 32,443,802 |
| Vanguard | 3,123,749 | Institution | 5.25% | 28,363,641 |
| Ishares | 2,897,710 | Institution | 4.87% | 26,311,207 |
| Vanguard Index Funds | 2,579,613 | Institution | 4.34% | 23,422,886 |
| Spdr | 946,333 | Institution | 1.59% | 8,592,704 |
| Chuck Royce | 909,137 | Institution | 1.53% | 8,254,964 |
| Janus Henderson | 794,538 | Institution | 1.34% | 7,214,405 |
| Dfa | 793,969 | Institution | 1.33% | 7,209,239 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Contrafund | 3,573,106 | Institution | 6.00% | 32,443,802 |
| Vanguard Index Funds | 2,579,613 | Institution | 4.34% | 23,422,886 |
| Fidelity Salem Street Trust | 727,028 | Institution | 1.22% | 6,601,414 |
| Fidelity Concord Street Trust | 625,716 | Institution | 1.05% | 5,681,501 |
| Dfa Investment Dimensions Group Inc | 445,825 | Institution | 0.75% | 4,048,091 |
| Vanguard Scottsdale Funds | 400,123 | Institution | 0.67% | 3,633,117 |
| Royce Fund | 262,646 | Institution | 0.44% | 2,384,826 |
| Tiaa-cref Funds | 255,619 | Institution | 0.43% | 2,321,021 |
| Allspring Funds Trust | 204,201 | Institution | 0.34% | 1,854,145 |
| Schwab Capital Trust | 183,916 | Institution | 0.31% | 1,669,957 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Total Stock Market ETF, VTI ETF | 1,899,706 | Institution | 3.19% | 20,839,775 |
| iShares Russell 2000 ETF, IWM ETF | 1,508,094 | Institution | 2.53% | 16,830,329 |
| Janus Henderson Small/Mid Cap Growth Alpha ETF, JSMD ETF | 794,538 | Institution | 1.34% | 9,415,275 |
| SPDR S&P Pharmaceuticals ETF, XPH ETF | 725,093 | Institution | 1.22% | 8,592,352 |
| Vanguard Extended Market ETF, VXF ETF | 667,855 | Institution | 1.12% | 7,326,369 |
| iShares Biotechnology ETF, IBB ETF | 447,491 | Institution | 0.75% | 4,994,000 |
| Dimensional U.S. Small Cap ETF, DFAS ETF | 377,319 | Institution | 0.63% | 4,471,230 |
| iShares Russell 2000 Value ETF, IWN ETF | 377,126 | Institution | 0.63% | 4,208,726 |
| Vanguard Russell 2000 ETF, VTWO ETF | 342,770 | Institution | 0.58% | 3,760,187 |
| Principal U.S. Small-Cap Multi-Factor ETF, PSC ETF | 241,153 | Institution | 0.41% | 2,857,663 |
FAQ
Who Owns Zevra Therapeutics (ZVRA)?
According to the latest TipRanks data, approximately 55.84% of the company's stock is held by institutional investors, 1.46% is held by insiders, and 42.70% is held by public companies and individual investors.
What percentage of Zevra Therapeutics (ZVRA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 55.84% of Zevra Therapeutics (ZVRA) stock is held by institutional investors: 17.08% by mutual funds, 16.89% by ETFs and 21.88% by other institutional investors.
What percentage of Zevra Therapeutics (ZVRA) stock is held by retail investors?
According to the latest TipRanks data, approximately 42.70% of Zevra Therapeutics (ZVRA) stock is held by public companies and individual investors.
Who owns the most shares of Zevra Therapeutics (ZVRA)?
BlackRock, Inc. owns the most shares of Zevra Therapeutics (ZVRA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

